Breaking News
0

Biotron Ltd (BIT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.025 -0.001    -3.85%
10:51:01 - Delayed Data. Currency in AUD ( Disclaimer )
Type: Equity
Market: Australia
ISIN: AU000000BIT4 
  • Volume: 381,006
  • Bid/Ask: 0.025 / 0.027
  • Day's Range: 0.025 - 0.026
Biotron Ltd 0.025 -0.001 -3.85%

BIT Overview

 
Information about the Biotron Ltd Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.026
Day's Range0.025 - 0.026
Revenue3.28M
Open0.026
52 wk Range0.016 - 0.046
EPS - 0
Volume381,006
Market Cap10.2M
Dividend (Yield)0 (N/A)
Average Volume (3m)282,929
P/E RatioN/A
Beta1.33
1-Year Change - 18.75%
Shares Outstanding391,314,760
Next Earnings DateN/A
What is your sentiment on Biotron Ltd?
or
Vote to see community's results!

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Falling Three Methods 1D Current
Completed Patterns
Three Inside Up 1D 2 Apr 18, 2018
Morning Doji Star 1W 3 Apr 01, 2018
Tri-Star Bearish 1H 3 Apr 18, 2018 14:00

Biotron Ltd News & Analysis

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  A2 Milk Company Ltd 11.820 12.020 11.750 -0.120 -1.01% 657.95K 11:16:03  
  Telstra Corporation. 3.070 3.080 3.060 -0.010 -0.32% 4.84M 11:29:59  
  Commonwealth Bank Australia 72.630 72.730 71.780 +0.570 +0.79% 755.23K 11:36:07  
  BHP Billiton Ltd 31.110 31.240 31.030 +0.250 +0.81% 1.31M 11:36:50  
  Facebook 166.28 168.43 165.81 -1.82 -1.08% 19.12M 21/04  
  ANZ Banking Group 26.980 27.100 26.625 +0.260 +0.97% 892.61K 11:31:21  
  National Australia Bank 28.655 28.745 28.325 +0.285 +1.00% 922.12K 11:36:14  
  Blackham Resources Ltd 0.074 0.075 0.074 0.000 0.00% 2.33M 11:14:33  
  Afterpay Touch 5.620 5.730 5.620 -0.020 -0.35% 122.61K 11:15:52  
  Pilbara Minerals Ltd 0.887 0.900 0.875 -0.008 -0.84% 1.28M 11:15:46  

Biotron Ltd Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

4

Equity Type

ORD

Biotron Limited is an Australia-based biotechnology company. The Company is engaged in the funding and management of intermediate, and applied biotechnology research and development projects. The Company is focused on the ongoing clinical development of its antiviral platform. The Company's lead antiviral drug, BIT225 is in mid-stage clinical development with approximately eight clinical trials completed. The Company has conducted clinical trails in human immunodeficiency virus-1 (HIV-1), hepatitis C virus (HCV) and HIV-1/HCV co-infected population. The clinical trials showed that BIT225 targets and reduces levels of HIV-1 residing in long-lived monocyte/macrophage reservoirs. BIT225 has clinical antiviral activity against both HIV-1 and HCV. BIT225 is pan-genotypic and is active against all HCV genotypes, including GT3. The Company designs and develops drugs that target a class of virus protein known as viroporins. Its earlier stage programs include Dengue, Influenza and others.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Join the discussion
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email